Cargando…

C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue

BACKGROUND: Bioactive soluble carbon nanostructures, such as the C(60) fullerene can bond with up to six electrons, thus serving by a powerful scavenger of reactive oxygen species similarly to many natural antioxidants, widely used to decrease the muscle fatigue effects. The aim of the study is to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Prylutskyy, Yurij I., Vereshchaka, Inna V., Maznychenko, Andriy V., Bulgakova, Nataliya V., Gonchar, Olga O., Kyzyma, Olena A., Ritter, Uwe, Scharff, Peter, Tomiak, Tomasz, Nozdrenko, Dmytro M., Mishchenko, Iryna V., Kostyukov, Alexander I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237293/
https://www.ncbi.nlm.nih.gov/pubmed/28086894
http://dx.doi.org/10.1186/s12951-016-0246-1
_version_ 1782495506455330816
author Prylutskyy, Yurij I.
Vereshchaka, Inna V.
Maznychenko, Andriy V.
Bulgakova, Nataliya V.
Gonchar, Olga O.
Kyzyma, Olena A.
Ritter, Uwe
Scharff, Peter
Tomiak, Tomasz
Nozdrenko, Dmytro M.
Mishchenko, Iryna V.
Kostyukov, Alexander I.
author_facet Prylutskyy, Yurij I.
Vereshchaka, Inna V.
Maznychenko, Andriy V.
Bulgakova, Nataliya V.
Gonchar, Olga O.
Kyzyma, Olena A.
Ritter, Uwe
Scharff, Peter
Tomiak, Tomasz
Nozdrenko, Dmytro M.
Mishchenko, Iryna V.
Kostyukov, Alexander I.
author_sort Prylutskyy, Yurij I.
collection PubMed
description BACKGROUND: Bioactive soluble carbon nanostructures, such as the C(60) fullerene can bond with up to six electrons, thus serving by a powerful scavenger of reactive oxygen species similarly to many natural antioxidants, widely used to decrease the muscle fatigue effects. The aim of the study is to define action of the pristine C(60) fullerene aqueous colloid solution (C(60)FAS), on the post-fatigue recovering of m. triceps surae in anaesthetized rats. RESULTS: During fatigue development, we observed decrease in the muscle effort level before C(60)FAS administration. After the application of C(60)FAS, a slower effort decrease, followed by the prolonged retention of a certain level, was recorded. An analysis of the metabolic process changes accompanying muscle fatigue showed an increase in the oxidative stress markers H (2) O (2) (hydrogen peroxide) and TBARS (thiobarbituric acid reactive substances) in relation to the intact muscles. After C(60)FAS administration, the TBARS content and H (2) O (2) level were decreased. The endogenous antioxidant system demonstrated a similar effect because the GSH (reduced glutathione) in the muscles and the CAT (catalase) enzyme activity were increased during fatigue. CONCLUSIONS: C(60)FAS leads to reduction in the recovery time of the muscle contraction force and to increase in the time of active muscle functioning before appearance of steady fatigue effects. Therefore, it is possible that C(60)FAS affects the prooxidant-antioxidant muscle tissue homeostasis, subsequently increasing muscle endurance.
format Online
Article
Text
id pubmed-5237293
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52372932017-01-18 C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue Prylutskyy, Yurij I. Vereshchaka, Inna V. Maznychenko, Andriy V. Bulgakova, Nataliya V. Gonchar, Olga O. Kyzyma, Olena A. Ritter, Uwe Scharff, Peter Tomiak, Tomasz Nozdrenko, Dmytro M. Mishchenko, Iryna V. Kostyukov, Alexander I. J Nanobiotechnology Research BACKGROUND: Bioactive soluble carbon nanostructures, such as the C(60) fullerene can bond with up to six electrons, thus serving by a powerful scavenger of reactive oxygen species similarly to many natural antioxidants, widely used to decrease the muscle fatigue effects. The aim of the study is to define action of the pristine C(60) fullerene aqueous colloid solution (C(60)FAS), on the post-fatigue recovering of m. triceps surae in anaesthetized rats. RESULTS: During fatigue development, we observed decrease in the muscle effort level before C(60)FAS administration. After the application of C(60)FAS, a slower effort decrease, followed by the prolonged retention of a certain level, was recorded. An analysis of the metabolic process changes accompanying muscle fatigue showed an increase in the oxidative stress markers H (2) O (2) (hydrogen peroxide) and TBARS (thiobarbituric acid reactive substances) in relation to the intact muscles. After C(60)FAS administration, the TBARS content and H (2) O (2) level were decreased. The endogenous antioxidant system demonstrated a similar effect because the GSH (reduced glutathione) in the muscles and the CAT (catalase) enzyme activity were increased during fatigue. CONCLUSIONS: C(60)FAS leads to reduction in the recovery time of the muscle contraction force and to increase in the time of active muscle functioning before appearance of steady fatigue effects. Therefore, it is possible that C(60)FAS affects the prooxidant-antioxidant muscle tissue homeostasis, subsequently increasing muscle endurance. BioMed Central 2017-01-13 /pmc/articles/PMC5237293/ /pubmed/28086894 http://dx.doi.org/10.1186/s12951-016-0246-1 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Prylutskyy, Yurij I.
Vereshchaka, Inna V.
Maznychenko, Andriy V.
Bulgakova, Nataliya V.
Gonchar, Olga O.
Kyzyma, Olena A.
Ritter, Uwe
Scharff, Peter
Tomiak, Tomasz
Nozdrenko, Dmytro M.
Mishchenko, Iryna V.
Kostyukov, Alexander I.
C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue
title C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue
title_full C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue
title_fullStr C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue
title_full_unstemmed C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue
title_short C(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue
title_sort c(60) fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237293/
https://www.ncbi.nlm.nih.gov/pubmed/28086894
http://dx.doi.org/10.1186/s12951-016-0246-1
work_keys_str_mv AT prylutskyyyuriji c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT vereshchakainnav c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT maznychenkoandriyv c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT bulgakovanataliyav c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT goncharolgao c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT kyzymaolenaa c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT ritteruwe c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT scharffpeter c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT tomiaktomasz c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT nozdrenkodmytrom c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT mishchenkoirynav c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue
AT kostyukovalexanderi c60fullereneaspromisingtherapeuticagentforcorrectingandpreventingskeletalmusclefatigue